NISIT RAWO 2seventy bio (NASDAQ:TSVT) traded higher premarket Thursday after announcing the completion of an asset purchase agreement under which Novo Nordisk (NVO) (OTCPK:NONOF) has acquired its Hemophilia A program and rights to certain other assets. The staff members working in the program will also join the pharma giant asContinue Reading
Bill Oxford Shares of Exact Sciences (NASDAQ:EXAS) traded higher on Wednesday after TD Cowen said that the company is seeking a 25% price hike from Medicare for its next-generation colorectal cancer screening test, Cologuard Plus. Analyst Dan Brennan reaffirmed his Buy rating on the stock, arguing that if approved, theContinue Reading
Viktor Cvetkovic/E+ via Getty Images MNC Capital Partners has increased its all-cash offer to acquire Vista Outdoor (NYSE:VSTO) to $42 per share, or about $3.2 billion, sending the sporting and outdoor goods company’s shares up in early trade. MNC Capital said, it believes that its acquisition of Vista (VSTO) isContinue Reading
Grandbrothers/iStock Editorial via Getty Images Ionis Pharmaceuticals (NASDAQ:IONS) traded higher Tuesday after the U.S. FDA accepted to review a marketing application for its anti-lipid therapy olezarsen, targeted at a rare genetic condition known as familial chylomicronemia syndrome (FCA). Granting priority review for Ionis’ (IONS) New Drug Application (NDA) for olezarsen,Continue Reading
ALFSnaiper/iStock Editorial via Getty Images Sphere Entertainment (NYSE:SPHR) rose to a 5.8% gain Tuesday afternoon after a late Monday filing disclosed an ownership stake held by investor and New York Mets owner Steve Cohen. The SEC filing noted Cohen and his Point72 Asset Management owned just over 1.56M shares, addingContinue Reading
Michael M. Santiago/Getty Images News Chipotle Mexican Grill (NYSE:CMG) edged higher on Tuesday, just ahead of the restaurant company’s 50-for-1 stock split that becomes effective after the closing bell. The stock split will be one of the biggest stock splits in New York Stock Exchange history. “We believe the stockContinue Reading
tylim Health Canada has authorized Eli Lilly’s atopic dermatitis treatment Ebglyss (lebrikizumab). The biologic is a first-line therapy for those 12 years and older. Ebglyss is given every four weeks, and trials showed that skin clearance and itch relief was seen as soon as four weeks. Ebglyss was approved inContinue Reading
Dilok Klaisataporn The stock market looks expensive, and valuation is in the top decile since 1960, but strong gains could still be ahead. Evercore ISI analysts raised their 2024 year-end S&P 500 (SP500) price target to 6,000, at around 24x trailing 12 months EPS. And according to an Evercore ISIContinue Reading
Boy Wirat Digital watermarking company Digimarc (NASDAQ:DMRC) rose after investment firm Needham upgraded the stock, citing expected strong recurring revenue growth. The stock was trading ~9.49% higher Monday noon at $28.73. Needham analyst Joshua Reilly took over the company’s coverage, and raised his recommendation on the stock to Buy fromContinue Reading
phototechno Amylyx Pharmaceuticals (NASDAQ:AMLX) has signed an agreement with Eiger BioPharmaceuticals (OTC:EIGRQ) to acquire the rights to the latter’s Phase 3-ready GLP-1 receptor antagonist, Avexitide. Cambridge, Massachusetts-based Amylyx (AMLX) has agreed to pay $35.1M plus other payments for the acquisition, the company announced in an SEC filing late Friday. TheContinue Reading
